Efficacy and safety of biological drugs in interstitial lung disease associated with connective tissue diseases-Reference-Cited by-同舟云学术

Efficacy and safety of biological drugs in interstitial lung disease associated with connective tissue diseases

Published:2021-09-01 Issue: Volume: Page:1-23
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Vicente-Rabaneda Esther F.¹,Serra López-Matencio José M.²,Ancochea Julio³⁴,Blanco Ricardo⁵,González-Gay Miguel Á.⁵⁶⁷,Castañeda Santos¹⁴

Affiliation:

1. Rheumatology Division, Hospital Universitario de La Princesa, Madrid, Spain

2. Hospital Pharmacy Division, Hospital Universitario de La Princesa, Madrid, Spain

3. Pneumology Division, Hospital Universitario de La Princesa, Madrid, Spain

4. Cathedra UAM-Roche, EPID-Future, Medicine Department, Universidad Autónoma de Madrid, Spain

5. Rheumatology Division, Hospital Universitario Marqués de Valdecilla, Spain

6. Department of Medicine, University of Cantabria, Santander, Spain

7. Faculty of Health Sciences, University of Witwatersrand, Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, South Africa

Funder

specific grant from funding agencies in the public

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1973428

Reference115 articles.

1. Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development

2. Pulmonary Pathology in Rheumatic Disease

3. Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment

4. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

5. Pulmonary Complications of Rheumatoid Arthritis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases;Frontiers in Immunology;2023-09-21